The exercise price for the warrants of series 2023/2024 TO2 in Cell Impact has been determined to SEK 0.17 and the subscription period starts today.
In December 2023, Cell Impact AB (publ) (Nasdaq First North Growth Market: CI) ("Cell Impact" or the "Company") carried out a rights issue of units. One (1) unit consisted of eight (8) newly issued shares and two (2) warrants of series 2023/2024 TO2. Each warrant gives the owner the right to subscribe for one (1) new share in the Company. The exercise price for the warrants of series 2023/2024 TO2 is to be determined to 70 percent of the volume-weighted average price of the Company’s share on Nasdaq First North Growth Market during the period 2 September 2024 up to and including 13 September